Követés
Miljan Kuljanin
Miljan Kuljanin
Harvard Medical School, Dana-Farber Cancer Institute
E-mail megerősítve itt: HMS.harvard.edu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries
M Kuljanin, DC Mitchell, DK Schweppe, AS Gikandi, DP Nusinow, ...
Nature biotechnology 39 (5), 630-641, 2021
2212021
Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
B Nabet, FM Ferguson, BKA Seong, M Kuljanin, AL Leggett, ML Mohardt, ...
Nature communications 11 (1), 4687, 2020
2122020
Neurons release serine to support mRNA translation in pancreatic cancer
RS Banh, DE Biancur, K Yamamoto, ASW Sohn, B Walters, M Kuljanin, ...
Cell 183 (5), 1202-1218. e25, 2020
2052020
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance
HN Bell, RJ Rebernick, J Goyert, R Singhal, M Kuljanin, SA Kerk, ...
Cancer cell 40 (2), 185-200. e6, 2022
1782022
Discovery of a selective inhibitor of doublecortin like kinase 1
FM Ferguson, B Nabet, S Raghavan, Y Liu, AL Leggett, M Kuljanin, ...
Nature chemical biology 16 (6), 635-643, 2020
992020
NCOA4-mediated ferritinophagy is a pancreatic cancer dependency via maintenance of iron bioavailability for iron–sulfur cluster proteins
N Santana-Codina, MQ Del Rey, KS Kapner, H Zhang, A Gikandi, ...
Cancer discovery 12 (9), 2180-2197, 2022
902022
A proteome-wide atlas of drug mechanism of action
DC Mitchell, M Kuljanin, J Li, JG Van Vranken, N Bulloch, DK Schweppe, ...
Nature biotechnology 41 (6), 845-857, 2023
772023
Collagenase treatment enhances proteomic coverage of low-abundance proteins in decellularized matrix bioscaffolds
M Kuljanin, CFC Brown, MJ Raleigh, GA Lajoie, LE Flynn
Biomaterials 144, 130-143, 2017
712017
Defining and targeting adaptations to oncogenic KRASG12C inhibition using quantitative temporal proteomics
N Santana-Codina, AS Chandhoke, Q Yu, B Małachowska, M Kuljanin, ...
Cell reports 30 (13), 4584-4599. e4, 2020
692020
An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML
S Lin, C Larrue, NK Scheidegger, BKA Seong, NV Dharia, M Kuljanin, ...
Cancer discovery 12 (2), 432-449, 2022
612022
High aldehyde dehydrogenase activity identifies a subset of human mesenchymal stromal cells with vascular regenerative potential
SE Sherman, M Kuljanin, TT Cooper, DM Putman, GA Lajoie, DA Hess
Stem Cells 35 (6), 1542-1553, 2017
592017
Coordinated transcriptional and catabolic programs support iron-dependent adaptation to RAS–MAPK pathway inhibition in pancreatic cancer
M Ravichandran, J Hu, C Cai, NP Ward, A Venida, C Foakes, M Kuljanin, ...
Cancer discovery 12 (9), 2198-2219, 2022
532022
Dynamic turn conformation of a short tryptophan-rich cationic antimicrobial peptide and its interaction with phospholipid membranes
M Nichols, M Kuljanin, M Nategholeslam, T Hoang, S Vafaei, B Tomberli, ...
The Journal of Physical Chemistry B 117 (47), 14697-14708, 2013
512013
Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
M Fan, W Lu, J Che, NP Kwiatkowski, Y Gao, HS Seo, SB Ficarro, ...
Elife 11, e78810, 2022
472022
Comparison of sample preparation techniques for large‐scale proteomics
M Kuljanin, DZ Dieters‐Castator, DA Hess, LM Postovit, GA Lajoie
Proteomics 17 (1-2), 1600337, 2017
472017
Proteomic characterisation reveals active Wnt-signalling by human multipotent stromal cells as a key regulator of beta cell survival and proliferation
M Kuljanin, GI Bell, SE Sherman, GA Lajoie, DA Hess
Diabetologia 60, 1987-1998, 2017
352017
Selective modulation of a pan-essential protein as a therapeutic strategy in cancer
CF Malone, NV Dharia, G Kugener, AB Forman, MV Rothberg, ...
Cancer discovery 11 (9), 2282-2299, 2021
322021
Proteomic analysis of ubiquitination substrates reveals a CTLH E3 ligase complex‐dependent regulation of glycolysis
MER Maitland, M Kuljanin, X Wang, GA Lajoie, C Schild‐Poulter
The FASEB Journal 35 (9), 2021
292021
Inhibition of aldehyde dehydrogenase-activity expands multipotent myeloid progenitor cells with vascular regenerative function
TT Cooper, SE Sherman, M Kuljanin, GI Bell, GA Lajoie, DA Hess
Stem Cells 36 (5), 723-736, 2018
252018
Characterization of a Vimentinhigh/Nestinhigh proteome and tissue regenerative secretome generated by human pancreas-derived mesenchymal stromal cells
TT Cooper, SE Sherman, GI Bell, J Ma, M Kuljanin, SE Jose, GA Lajoie, ...
Stem Cells 38 (5), 666-682, 2020
242020
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20